Related Experiment Video

Updated: Aug 25, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

[Peptic ulcer in children]

Atsushi Sawada1

  • 1Department of Pediatrics, Osaka Police Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 25, 2004
PubMed

Insights

Helicobacter pylori (H. pylori) infection is a primary cause of peptic ulcers in children. Current guidelines require endoscopy for diagnosis, but new non-invasive methods and antibiotic resistance necessitate updated pediatric H. pylori guidelines.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is the leading cause of peptic ulcer disease in pediatric populations.
  • Existing guidelines for H. pylori diagnosis and eradication in children were established by the Japan Pediatric H. pylori Research Meeting.
  • Current diagnostic methods often require invasive procedures like endoscopy, posing challenges for pediatric patients.

Purpose of the Study:

  • To review the current diagnostic and therapeutic guidelines for H. pylori infection in children.
  • To highlight the need for updated guidelines considering advancements in non-invasive diagnostic tools and emerging antibiotic resistance.

Main Methods:

  • Review of existing pediatric H. pylori guidelines.
  • Discussion of diagnostic methods, including invasive (endoscopy) and emerging non-invasive techniques.
  • Consideration of eradication therapy and challenges such as clarithromycin resistance.

Main Results:

  • Eradication therapy for H. pylori can effectively resolve abdominal symptoms in many pediatric patients.
  • The necessity of endoscopy for diagnosis in children remains a significant limitation.
  • Development of new non-invasive diagnostic devices and increasing prevalence of clarithromycin-resistant H. pylori strains are noted.

Conclusions:

  • Updated guidelines for diagnosing and treating H. pylori in children are urgently needed.
  • Future guidelines should incorporate non-invasive diagnostic options and address antibiotic resistance patterns.
  • The goal is to improve patient outcomes and reduce the burden of invasive procedures in pediatric H. pylori management.

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...